Use of monoclonal antibodies in cancer immunotherapy: types and mechanisms of action

• Egile Nagusiak: Paola Damián-Blanco (Egilea), Selene Ahuexoteco-Sánchez (Egilea), Adrián A. Carbajal-Gallardo (Egilea), Fredi C. Coctecon-Chávelas (Egilea), Cynthia Rodríguez-Nava (Egilea), Amalia Vences-Velázquez (Egilea), Yolanda Medina-Flores (Egilea), Olga Mata-Ruíz (Egilea), Lourdes Lloret-Sánchez (Egilea), Karen Cortés-Sarabia (Egilea)
• Formatua: Liburua
• Argitaratua: Permanyer, 2023-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Immunotherapy is one of the most innovative treatments in the current field of oncology and consists of stimulating the immune system to eliminate tumoral cells. Monoclonal antibodies (mAbs) are glycoproteins secreted by B-cells capable of recognizing and neutralizing foreign organisms or antigens....